Clinical Trial Update: Effect of Alendronate With β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-osseous Defects. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating alendronate combined with a beta-tricalcium phosphate bone substitute for surgical treatment of intrabony periodontal defects;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Beta-tricalcium phosphate bone substitute (beta-tricalcium phosphate)
• alendronate (alendronate)

Snippet

Sponsor: Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre | Conditions: Intrabony Periodontal Defect | Phase 4 | Status: COMPLETED